Legal Entity
AMILI
Country of registration | Singapore |
Registration number | 201922200N |
Local SIC | |
Incorporation date | 10 Jul 2019 |
Company age | 6 years 10 months |
Official entity type | Private Limited Company |
No. of officers | 71 |
Contact
89 SCIENCE PARK DRIVE, #03-09, THE RUTHERFORD, Singapore 118261
This is the legal entity page of AMILI. To access company info, company size, news , key makers’ emails, visit the profile pages above.
- AMILIView MoreSingaporeAMILI is a precision gut microbiome company based in Singapore, leveraging cutting-edge technology and regional expertise to develop innovative diagnostics, predictive algorithms, and microbiome-modifying interventions. Our consumer health arm, BIO & ME, offers personalized solutions through insights from our comprehensive database and proprietary analytics engine, PRIME. Additionally, AMILI operates Southeast Asia's first and only gut microbiome bank for clinical use and research, providing unparalleled opportunities for advancing scientific understanding and improving human health.
Auditor | ZHONGLEI SINGAPORE |
Revenue | > 10m |
Share Capital - Preference shares | USD 14,668,248 |
Share Capital - Ordinary shares | USD 2,594,625 |
- AMGEN SINGAPORE MANUFACTURING PTE. LTD.

- AMILI

- ASTRAZENECA PHARMACEUTICALS SINGAPORE

- BEECHAM PHARMACEUTICALS (PTE) LTD.

- BIOPTIMAL INTERNATIONAL

- BIOSENSORS INTERVENTIONAL TECHNOLOGIES PTE. LTD.

- EDWARDS LIFESCIENCES (SINGAPORE)

- GLAXO WELLCOME MANUFACTURING PTE LTD

- LONZA BIOLOGICS TUAS

- LONZA BIOSCIENCE SINGAPORE

Frequently Asked Questions (FAQ)
- What is the address of AMILI?
- Where is AMILI's headquarter?
- What is AMILI's contact number?
- What AMILI's spending power?
- Does AMILI have a presence in the domain it operates in?
